期刊文献+

乳腺癌前哨淋巴结CK_(19) mRNA和蛋白的表达 被引量:1

Expression of CK_(19) mRNA and protein in SLN of breast cancers
下载PDF
导出
摘要 目的探讨CK19微转移分子在乳腺癌前哨淋巴结(SLN)的表达情况及意义。方法采用免疫组化S-P法及原位杂交技术检测66例SLN中CK19微转移分子的表达。同时与常规病检法比较其检测敏感性。并比较转移组、微转移组、无转移组患者的临床资料。结果66例SLN在常规病理检查阴性38例淋巴结中6例表达CK19蛋白15.8%(6/38),8例21.1%(8/38)表达CK19mR-NA。原位杂交法与常规病检法转移的检出率相比较,差异有统计学意义(P<0.05)。CK19蛋白和mRNA表达之间差异无统计学意义(P>0.05)。同时乳腺癌转移组与微转移组患者在肿物大小与淋巴管浸润上有相似性,而同无转移组差异有统计学意义(P<0.05)。结论免疫组化法和原位杂交法较常规病理检查更为敏感。通过免疫组化法和原位杂交法的联合使用,可明显提高乳腺癌SLN微转移的检出率,同时也证明原位杂交法是可靠的,比免疫组化更为敏感的技术。SLN微转移有可能作为肿瘤预后的指标。 Objective To investigate the significance of CK19 micrometastasis expression in sentinel lymph node(SLN) of breast cancer. Methods Paraffin embedded tissues from 66 SLNs were analyzed for CK19 expression by immunohistochemistry(IHC) and in situ hybridization ( ISH ) techniques. The sensitivity of the method of IHC was compar with that routin pathologic examination.At the same time, various clinic pathologic parameters were contrasted among metastasis negative group,mlcro-metastasis group and nonmetastasis group. Results 38 metastasis negative patients detected by the routine pathology, 6 of which CK19 protein expression was positive by IHC method. 8 of 38 metastasis negative patients detected by the routine pathology, in which CK19 mRNA positive detected by ISH method, The detection of metastasis rate of SLN had significant difference between ISH and the routine pathologic examination ( P 〈 0.05). Between expression of CK19 protein and CK19 mRNA had no stafiscal difference ( P 〉0.05). The micro-metastasis group was similar with the metastasis group in tumor size and lymphatic vessel invasion,which was significantly ( P 〈0.05) different with that of metastasis- negative group. Conclusion The IHC and ISH is more sensitive than the routine pathological method for the detection of micmmetastasis. The combinated utilization of ICH and ISH can greatly improve the detective efficiency of micro-metastasis in SLNs. The ISH is more sensitive than the ICH method for the detection of micmmetastasis. Micmmetastasis in SLN maybe used as a prognostic indicator.
出处 《实用肿瘤学杂志》 CAS 2007年第1期28-31,共4页 Practical Oncology Journal
基金 湖南省教育厅基金项目(编号:06C786)
关键词 乳腺肿瘤 微转移 前哨淋巴结 原位杂交 免疫组织化学 Brast-neoplasms Cytokeratin19 Sentinel-lymph-node In-situ hybridization Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献42

  • 1于满,杨毅,牛瑞芳,史玉荣,魏熙胤,张霖,王德发.同源异型盒基因BP1在乳腺癌组织中的表达及其临床意义[J].癌症,2004,23(7):855-859. 被引量:9
  • 2Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel lymph node biopsy : Results of a prospective randomized trial of two techniques[J]. Surgery, 1999, 126: 714-722.
  • 3Turner RR, Ollila DW, Stem S, et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging[J]. Am J Surg Pathol, 1999, 23: 263-267.
  • 4Wong JH. Sentinel lymphadenectomy in breast cancer[J]. Surg Clin North Am, 2000, 80: 1521-1530.
  • 5Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breastcancer[J]. N Engl J Med, 2002, 347(16) :1233-1241.
  • 6Turner RR, OUila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast cancer [J].Ann Surg, 1997, 226(3) : 271-278.
  • 7Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenctomy in breast cancer[J]. J Clin Oncol, 1997, 15(6): 2345-2350.
  • 8Noguchi S, Aihara T, Motomura K et al. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction[J].Cancer,1996,78(6):1235-1240.
  • 9Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelial,tumors and cultured cells[J]. Cell,1982,31(1):11-24.
  • 10Traweek ST, Liu J, Battifora H. Keratin gene expression in non-epithelial tissues.Detection with polymerase chain reaction[J].J Pathbo,1993,142(4):1111-1118.

共引文献12

同被引文献9

  • 1黄俊辉,海健,李洋,唐利立,毛杰,申郑堂,胡铁辉.原发性乳腺癌组织中c-erbB-2和nm23的表达及其意义[J].中国普通外科杂志,2004,13(11):861-863. 被引量:11
  • 2李树玲.乳腺癌外科治疗新进展[J].临床外科杂志,2005,13(1):10-11. 被引量:5
  • 3宋昌龙,邢华,续哲莉.乳腺癌前哨淋巴结活检技术的原理及研究进展[J].实用肿瘤学杂志,2005,19(1):72-74. 被引量:2
  • 4付荣湛,阮长乐,于学智,曹莉莉,孙青,顾禾,张丽丽.CK-19检测在乳腺癌前哨淋巴结微转移诊断中的价值[J].山东医药,2005,45(8):9-11. 被引量:4
  • 5Noguchi M, Katv N, Miyazaki, I, Diagnosis of axillary lymph node metastases in patients with breast cancer[ J]. Breast Cancer Res Treat, 1996; 40:283-93.
  • 6Greager AJ, Geising KR, Shiver SA ,et al. Intraoperative valuation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology [J]. Mod Pathol,2007;15 (11) :1140-7.
  • 7Ludwig Breast Caner Study Groop. Prognostic importance of occult axillary lymph node micrometastases from breast cancer [ J ]. Lancet, 1990;335:1565.
  • 8Masarel ID, Bonichon F, Coindre TM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special technique : revaluation with longer follow-up [ J ]. Br J Cancer, 1992 ; 66:523-7.
  • 9Mc Gukin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer, their detection and prognosis significance [ J]. Br J Cancer,1996 ;73:88-95.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部